查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1869674

人体组成监测仪市场规模、份额和趋势分析报告：按产品、最终用途、地区和细分市场预测（2025-2033 年）

Body Composition Analyzers Market Size, Share & Trends Analysis Report By Product, By End-use By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

人体成分监测仪市场摘要

2024年全球人体组成监测仪市场规模估计为7.142亿美元，预计2033年将达到12.616亿美元。

预计从 2025 年到 2033 年，该行业将以 6.4% 的复合年增长率成长。这一增长是由人们对肥胖和慢性疾病的认识不断提高、健身和健康趋势的日益增长以及预防性护理的普及所推动的。

包括携带式和易用型设备在内的技术进步进一步推动了市场需求。此外，对运动科学、职场健康计画和医疗保健基础设施的投资不断增加，也为市场扩张提供了支持。

由于肥胖率上升、代谢性疾病盛行率增加以及消费者健康意识增强，全球人体组成分析仪产业正经历快速成长。预计到2030年，全球将有11.3亿成年人患有肥胖症，到2024年，将有5.06亿人患有代谢性疾病。传统的BMI等指标往往无法检测出肌肉少症性肥胖，这种肥胖症的特征是高脂肪和低肌肉量并存。因此，临床指南越来越多地推荐基于电阻活检的人体组成分析，因为该方法可以更准确地评估脂肪量、肌肉量、内臟脂肪量和水分含量。这种转变使分析仪从可有可无的工具转变为预防和临床护理中必不可少的设备，使其成为医疗诊断市场的核心组成部分。

医疗系统和保险公司正在进一步推动市场扩张。支付方正在推出奖励，鼓励早期代谢检测，因为早期风险分层有助于降低长期治疗成本。医院和诊所正在将体成分监测仪纳入年度健康筛检计画、减重手术治疗流程和营养不良筛检通讯协定。例如，2025 年美国医师收费标准将涵盖使用电阻影像技术进行肌肉量评估的费用，欧洲的支付方也在回应全球营养不良领导力倡议，扩大肌肉减少症诊断的覆盖范围。这些政策降低了小规模诊所和基层医疗机构采用该技术的门槛，从而将市场扩展到大型医院之外。企业健康计画也越来越补贴内部扫描费用，进一步扩大了参保用户群体。在亚太地区，由于试验研究表明该技术有助于降低糖尿病和心血管疾病相关支出，预计该地区将更广泛地采用该技术，这表明该地区未来具有成长潜力。

政府主导也正在推动人体组成分析仪的普及应用。例如，位于新德里的全印度医学科学研究所（AIIMS）于2024年初透过政府电子市场（GeM）购买了一台人体组成分析仪，显示政府致力于向公共医疗机构引进先进的诊断设备。

主导需求同样重要。人们对维持精瘦体脂肪和健康老龄化的意识日益增强，导致社群媒体上「瘦胖」现象的兴起。健身爱好者、运动员和健身房会员不再只关注体重，而是更重视追踪体脂率、水分含量和内臟脂肪。零售商报告称，智慧体重计的销量实现了两位数的增长，而健康应用程式则将电阻测量与饮食和运动计划相结合。 Hume Health Body Pod 等设备（于 2025 年 9 月发布）正是这一趋势的体现。 Body Pod 采用多频生物电电阻分析技术，可提供 40 多项健康指标，包括体脂率、骨骼肌品质、体总水分、内臟脂肪指数和基础代谢率。分段分析功能可以追踪特定身体部位（例如手臂、腿部和躯干）的数据，从而为训练、恢復和长期健康趋势提供切实可行的建议。其居家使用、非侵入式的设计使其易于使用，弥合了消费者市场和临床市场之间的差距。

目录

第一章调查方法和范围

第二章执行摘要

第三章：体组成监测仪市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 人体成分分析仪市场分析工具
    • 产业分析—波特五力分析
    • PESTEL 分析

第四章 人体组成监测仪市场：依产品分類的估算与趋势分析

  • 细分仪表板
  • 产品变异分析
  • 人体组成监测仪市场规模及趋势分析（依产品划分），2021-2033年
  • 卡尺
  • 电阻分析仪
  • 静压计量
  • 双能量X射线检测法（DEXA）
  • 空气血管脉动血流量记录
  • 其他的

第五章：体成分监测仪市场：依最终用途分類的估算与趋势分析

  • 细分仪表板
  • 依最终用途进行变异分析
  • 2021-2033年依最终用途分類的人体组成监测仪市场规模及趋势分析
  • 医院和诊所
  • 健身中心/健身房
  • 居家护理中心

第六章 人体组成监测仪市场：区域估算与趋势分析

  • 2025年及2033年区域市占率分析
  • 区域市场概览
  • 区域概况
  • 市场规模、预测趋势分析（2021-2033年）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争情势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 主要企业市占率分析，2025 年
  • Company Position Analysis
  • 公司分类（新兴企业、创新者、领导者）
  • 公司简介
    • Hologic Inc.
    • Bodystat Ltd
    • COSMED Srl
    • Charder Electronic Co. Ltd
    • InBody Co. Ltd
    • GE Healthcare
    • Tanita Corporation
    • Omron Corporation
    • Seca GmbH
    • Maltron International
Product Code: GVR-4-68040-760-5

Body Composition Analyzers Market Summary

The global body composition analyzers market size was estimated at USD 714.2 million in 2024 and is projected to reach USD 1,261.6 million by 2033, growing at a CAGR of 6.4% from 2025 to 2033. This growth is driven by rising awareness of obesity and chronic diseases, increasing fitness and wellness trends, and growing adoption of preventive healthcare.

Technological advancements, including portable and user-friendly devices, further fuel demand. In addition, rising investments in sports science, workplace wellness programs, and healthcare infrastructure support market expansion.

The global body composition analyzers industry is experiencing rapid growth, driven by rising obesity rates, increasing metabolic disorders, and heightened consumer health awareness. Obesity is projected to affect 1.13 billion adults by 2030, while in 2024, 506 million people are reported to have metabolic disorders. Traditional metrics like BMI often fail to detect sarcopenic obesity, where high fat and low muscle mass coexist. As a result, clinical guidelines increasingly favor impedance-based body composition analysis, which offers a more precise assessment of fat, muscle, visceral adiposity, and hydration levels. This shift is transforming analyzers from optional tools into essential devices in both preventative and clinical care, making them a core segment of the healthcare diagnostic market.

Healthcare systems and insurers are further fueling market expansion. Payer incentives now reward early risk stratification, as detecting metabolic deterioration early reduces long-term treatment costs. Hospitals and clinics are incorporating body composition analyzers into annual wellness programs, bariatric surgery pathways, and malnutrition screening protocols. For example, the 2025 U.S. Physician Fee Schedule reimburses impedance-based muscle-mass assessments, while European payers increasingly cover sarcopenia diagnostics following the Global Leadership Initiative on Malnutrition. This policy develops lower barriers for small clinics and primary care offices, expanding the market beyond large hospitals. Corporate wellness programs also subsidize onsite scans, further enlarging the reimbursed user base. In Asia Pacific, broader adoption is expected as pilot studies demonstrate reductions in diabetes- and cardiovascular-related expenditures, indicating future regional growth potential.

Government initiatives further bolster the adoption of body composition analyzers. For instance, the All-India Institute of Medical Sciences (AIIMS) in New Delhi procured a body composition analyzer through the Government e-Marketplace (GeM) in early 2024, indicating the government's commitment to integrating advanced diagnostic tools in public healthcare institutions

Consumer-driven demand is equally significant. Awareness of lean mass preservation and healthy aging has risen, with social media highlighting the "skinny-fat" phenomenon. Fitness enthusiasts, athletes, and gym members now prioritize tracking fat percentage, hydration, and visceral fat over simple weight. Retailers report double-digit growth in connected scales, while health apps integrate impedance results with diet and exercise plans. Devices like the Hume Health Body Pod, launched in September 2025, exemplify this trend. Using multi-frequency bioelectrical impedance analysis, the Body Pod provides over 40 health metrics, including body fat, skeletal muscle, total body water, visceral fat index, and basal metabolic rate. Segmental analysis allows users to track specific regions, arms, legs, and trunks, offering actionable insights for training, recovery, and long-term health trends. Its home-based, non-invasive design makes it accessible, bridging the consumer and clinical segments of the market.

Global Body Composition Analyzers Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global body composition analyzers market report based on product, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Calipers
  • Bioimpedance Analyzers
  • Hydrostatic Weighing
  • DEXA (Dual-Energy X-Ray Absorptiometry)
  • Air-Displacement Plethysmography
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics
  • Fitness Centers and Gymnasiums
  • Homecare Center
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Body Composition Analyzers Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Body Composition Analyzers Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Body Composition Analyzers Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Body Composition Analyzers Product Market Movement Analysis
  • 4.3. Global Body Composition Analyzers Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Calipers
    • 4.4.1. Calipers market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Bioimpedance Analyzers
    • 4.5.1. Bioimpedance analyzers market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. Hydrostatic Weighing
    • 4.6.1. Hydrostatic Weighing market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.7. DEXA (Dual-Energy X-Ray Absorptiometry)
    • 4.7.1. DEXA (Dual-Energy X-Ray Absorptiometry) market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.8. Air-Displacement Plethysmography
    • 4.8.1. Air-Displacement Plethysmography market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.9. Others
    • 4.9.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Body Composition Analyzers Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Body Composition Analyzers End Use Market Movement Analysis
  • 5.3. Global Body Composition Analyzers Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 5.4. Hospitals & Clinics
    • 5.4.1. Hospitals & Clinics market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Fitness Centers and Gymnasiums
    • 5.5.1. Fitness Centers and Gymnasiums market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Homecare Center
    • 5.6.1. Homecare Center market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Body Composition Analyzers Market: Regional Estimates & Trend Analysis By Product, End Use

  • 6.1. Regional Market Share Analysis, 2025 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Competitive scenario
      • 6.5.1.3. Regulatory framework
      • 6.5.1.4. Reimbursement structure
      • 6.5.1.5. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Competitive scenario
      • 6.5.2.3. Regulatory framework
      • 6.5.2.4. Reimbursement structure
      • 6.5.2.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Competitive scenario
      • 6.5.3.3. Regulatory framework
      • 6.5.3.4. Reimbursement structure
      • 6.5.3.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Competitive scenario
      • 6.6.1.3. Regulatory framework
      • 6.6.1.4. Reimbursement structure
      • 6.6.1.5. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement structure
      • 6.6.2.5. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Competitive scenario
      • 6.6.3.3. Regulatory framework
      • 6.6.3.4. Reimbursement structure
      • 6.6.3.5. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Competitive scenario
      • 6.6.4.3. Regulatory framework
      • 6.6.4.4. Reimbursement structure
      • 6.6.4.5. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Competitive scenario
      • 6.6.5.3. Regulatory framework
      • 6.6.5.4. Reimbursement structure
      • 6.6.5.5. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Competitive scenario
      • 6.6.6.3. Regulatory framework
      • 6.6.6.4. Reimbursement structure
      • 6.6.6.5. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Competitive scenario
      • 6.6.7.3. Regulatory framework
      • 6.6.7.4. Reimbursement structure
      • 6.6.7.5. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Competitive scenario
      • 6.6.8.3. Regulatory framework
      • 6.6.8.4. Reimbursement structure
      • 6.6.8.5. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Competitive scenario
      • 6.7.1.3. Regulatory framework
      • 6.7.1.4. Reimbursement structure
      • 6.7.1.5. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement structure
      • 6.7.2.5. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement structure
      • 6.7.3.5. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement structure
      • 6.7.4.5. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Competitive scenario
      • 6.7.5.3. Regulatory framework
      • 6.7.5.4. Reimbursement structure
      • 6.7.5.5. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Competitive scenario
      • 6.7.6.3. Regulatory framework
      • 6.7.6.4. Reimbursement structure
      • 6.7.6.5. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Competitive scenario
      • 6.8.1.3. Regulatory framework
      • 6.8.1.4. Reimbursement structure
      • 6.8.1.5. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Competitive scenario
      • 6.8.2.3. Regulatory framework
      • 6.8.2.4. Reimbursement structure
      • 6.8.2.5. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Competitive scenario
      • 6.9.1.3. Regulatory framework
      • 6.9.1.4. Reimbursement structure
      • 6.9.1.5. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Competitive scenario
      • 6.9.2.3. Regulatory framework
      • 6.9.2.4. Reimbursement structure
      • 6.9.2.5. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Competitive scenario
      • 6.9.3.3. Regulatory framework
      • 6.9.3.4. Reimbursement structure
      • 6.9.3.5. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Competitive scenario
      • 6.9.4.3. Regulatory framework
      • 6.9.4.4. Reimbursement structure
      • 6.9.4.5. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Key company market share analysis, 2025
  • 7.4. Company Position Analysis
  • 7.5. Company Categorization (Emerging Players, Innovators and Leaders)
  • 7.6. Company Profiles
    • 7.6.1. Hologic Inc.
      • 7.6.1.1. Company overview
      • 7.6.1.2. Financial performance
      • 7.6.1.3. Product benchmarking
      • 7.6.1.4. Strategic initiatives
    • 7.6.2. Bodystat Ltd
      • 7.6.2.1. Company overview
      • 7.6.2.2. Financial performance
      • 7.6.2.3. Product benchmarking
      • 7.6.2.4. Strategic initiatives
    • 7.6.3. COSMED Srl
      • 7.6.3.1. Company overview
      • 7.6.3.2. Financial performance
      • 7.6.3.3. Product benchmarking
      • 7.6.3.4. Strategic initiatives
    • 7.6.4. Charder Electronic Co. Ltd
      • 7.6.4.1. Company overview
      • 7.6.4.2. Financial performance
      • 7.6.4.3. Product benchmarking
      • 7.6.4.4. Strategic initiatives
    • 7.6.5. InBody Co. Ltd
      • 7.6.5.1. Company overview
      • 7.6.5.2. Financial performance
      • 7.6.5.3. Product benchmarking
      • 7.6.5.4. Strategic initiatives
    • 7.6.6. GE Healthcare
      • 7.6.6.1. Company overview
      • 7.6.6.2. Financial performance
      • 7.6.6.3. Product benchmarking
      • 7.6.6.4. Strategic initiatives
    • 7.6.7. Tanita Corporation
      • 7.6.7.1. Company overview
      • 7.6.7.2. Financial performance
      • 7.6.7.3. Product benchmarking
      • 7.6.7.4. Strategic initiatives
    • 7.6.8. Omron Corporation
      • 7.6.8.1. Company overview
      • 7.6.8.2. Financial performance
      • 7.6.8.3. Product benchmarking
      • 7.6.8.4. Strategic initiatives
    • 7.6.9. Seca GmbH
      • 7.6.9.1. Company overview
      • 7.6.9.2. Financial performance
      • 7.6.9.3. Product benchmarking
      • 7.6.9.4. Strategic initiatives
    • 7.6.10. Maltron International
      • 7.6.10.1. Company overview
      • 7.6.10.2. Financial performance
      • 7.6.10.3. Product benchmarking
      • 7.6.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America body composition analyzers market, By country, 2021 - 2033 (USD Million)
  • Table 3 North America body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 4 North America body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 5 U.S. body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 6 U.S. body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 7 Canada body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 8 Canada body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 9 Mexico body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 10 Mexico body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 11 Europe body composition analyzers market, By country, 2021 - 2033 (USD Million)
  • Table 12 Europe body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 13 Europe body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 14 UK body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 15 UK body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 16 Germany body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 17 Germany body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 18 France body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 19 France body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 20 Italy body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 21 Italy body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 22 Denmark body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 23 Denmark body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 24 Sweden body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 25 Sweden body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 26 Norway body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 27 Norway body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 28 Asia Pacific body composition analyzers market, By country, 2021 - 2033 (USD Million)
  • Table 29 Asia Pacific body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 30 Asia Pacific body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 31 Japan body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 32 Japan body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 33 China body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 34 China body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 35 India body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 36 India body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 37 Australia body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 38 Australia body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 39 South Korea body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 40 South Korea body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 41 Thailand body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 42 Thailand body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 43 Latin America body composition analyzers market, By Country, 2021 - 2033 (USD Million)
  • Table 44 Latin America body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 45 Latin America body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 46 Brazil body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 47 Brazil body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 48 Argentina body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 49 Argentina body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 50 Middle East & Africa body composition analyzers market, By country, 2021 - 2033 (USD Million)
  • Table 51 Middle East & Africa body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 52 Middle East & Africa body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 53 South Africa body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 54 South Africa body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 55 Saudi Arabia body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 56 Saudi Arabia body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 57 UAE body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 58 UAE body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 59 Kuwait body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 60 Kuwait body composition analyzers market, By end use, 2021 - 2033 (USD Million)

List of Figure

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Body composition analyzers market: Market outlook
  • Fig. 14 Body composition analyzers market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Body composition analyzers market driver impact
  • Fig. 20 Body composition analyzers restraint impact
  • Fig. 21 Body composition analyzers market: product movement analysis
  • Fig. 22 Body composition analyzers market: product outlook and key takeaways
  • Fig. 23 Calipers market estimates and forecast, 2021 - 2033
  • Fig. 24 Bioimpedance Analyzers market estimates and forecast, 2021 - 2033
  • Fig. 25 Hydrostatic Weighing market estimates and forecast, 2021 - 2033
  • Fig. 26 DEXA (Dual-Energy X-Ray Absorptiometry) market estimates and forecast, 2021 - 2033
  • Fig. 27 Air-Displacement Plethysmography market estimates and forecasts, 2021 - 2033
  • Fig. 28 Others market estimates and forecast, 2021 - 2033
  • Fig. 29 Body composition analyzers market: end use movement analysis
  • Fig. 30 Body composition analyzers market: end use outlook and key takeaways
  • Fig. 31 Hospitals & Clinics market estimates and forecast, 2021 - 2033
  • Fig. 32 Fitness Centers and Gymnasiums market estimates and forecast, 2021 - 2033
  • Fig. 33 Homecare Center market estimates and forecast, 2018-2033
  • Fig. 34 Global Body Composition Analyzers Market: regional movement analysis
  • Fig. 35 Global Body Composition Analyzers Market: regional outlook and key takeaways
  • Fig. 36 North America
  • Fig. 37 North America market estimates and forecast, 2021 - 2033
  • Fig. 38 U.S.
  • Fig. 39 U.S. market estimates and forecast, 2021 - 2033
  • Fig. 40 Canada
  • Fig. 41 Canada market estimates and forecast, 2021 - 2033
  • Fig. 42 Mexico
  • Fig. 43 Mexico market estimates and forecast, 2021 - 2033
  • Fig. 44 Europe
  • Fig. 45 Europe. market estimates and forecast, 2021 - 2033
  • Fig. 46 UK
  • Fig. 47 UK market estimates and forecast, 2021 - 2033
  • Fig. 48 Germany
  • Fig. 49 Germany market estimates and forecast, 2021 - 2033
  • Fig. 50 France
  • Fig. 51 France market estimates and forecast, 2021 - 2033
  • Fig. 52 Italy
  • Fig. 53 Italy market estimates and forecast, 2021 - 2033
  • Fig. 54 Spain
  • Fig. 55 Spain market estimates and forecast, 2021 - 2033
  • Fig. 56 Denmark
  • Fig. 57 Denmark market estimates and forecast, 2021 - 2033
  • Fig. 58 Sweden
  • Fig. 59 Sweden market estimates and forecast, 2021 - 2033
  • Fig. 60 Norway
  • Fig. 61 Norway market estimates and forecast, 2021 - 2033
  • Fig. 62 Asia Pacific
  • Fig. 63 Asia Pacific market estimates and forecast, 2021 - 2033
  • Fig. 64 Japan
  • Fig. 65 Japan market estimates and forecast, 2021 - 2033
  • Fig. 66 China
  • Fig. 67 China market estimates and forecast, 2021 - 2033
  • Fig. 68 India
  • Fig. 69 India market estimates and forecast, 2021 - 2033
  • Fig. 70 South Korea
  • Fig. 71 South Korea market estimates and forecast, 2021 - 2033
  • Fig. 72 Thailand
  • Fig. 73 Thailand market estimates and forecast, 2021 - 2033
  • Fig. 74 Australia
  • Fig. 75 Australia market estimates and forecast, 2021 - 2033
  • Fig. 76 Latin America
  • Fig. 77 Latin America market estimates and forecast, 2021 - 2033
  • Fig. 78 Brazil
  • Fig. 79 Brazil market estimates and forecast, 2021 - 2033
  • Fig. 80 Argentina
  • Fig. 81 Argentina market estimates and forecast, 2021 - 2033
  • Fig. 82 Middle East and Africa
  • Fig. 83 Middle East and Africa. market estimates and forecasts, 2021 - 2033
  • Fig. 84 Saudi Arabia
  • Fig. 85 Saudi Arabia market estimates and forecast, 2021 - 2033
  • Fig. 86 South Africa
  • Fig. 87 South Africa market estimates and forecast, 2021 - 2033
  • Fig. 88 UAE
  • Fig. 89 UAE market estimates and forecast, 2021 - 2033
  • Fig. 90 Kuwait
  • Fig. 91 Kuwait market estimates and forecast, 2021 - 2033
  • Fig. 92 Participant categorization- Body composition analyzers market
  • Fig. 93 Market share of key market players- Body composition analyzers market